Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10714413.1Aexternal-prioritypatent/EP2419086B1/en
Application filed by Bristol-Myers Squibb CompanyfiledCriticalBristol-Myers Squibb Company
Publication of CY1114434T1publicationCriticalpatent/CY1114434T1/en
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms
(AREA)
Medicinal Preparation
(AREA)
Abstract
Παρέχονται άμορφες στερεάς διασποράς συνθέσεις που περιέχουν (2R)-2[[(4-χλωροφαινυλ)σουλφονυλ][[2-φθορο-4-(1,2,4-οξαδιαζολ-3-υλ)φαινυλ]μεθυλ]αμινο]-5,5,5- τριφθοροπενταναμίδιο και είτε πολυβινυλοπυρρολιδόνη-οξεικό βινύλ εστέρα είτε ηλεκτρική οξεική υδροξυπροπύλ-μεθυλοκυτταρίνη για δισκιοποίηση.Amorphous solid dispersible compositions containing (2R) -2 [[(4-chlorophenyl) sulfonyl] [[2-fluoro-4- (1,2,4-oxadiazol-3-yl) phenyl] methyl] amino] -5 are provided , 5,5-trifluoropentanamide and either polyvinylpyrrolidone-vinyl acetate or hydroxypropyl-methylcellulose acetate for tableting.